Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Neonatal Opioid Withdrawal Syndrome: later-stage trial registry

2 of 8 indexed Neonatal Opioid Withdrawal Syndrome trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Neonatal Opioid Withdrawal Syndrome: 8 US clinical trials tracked, 2 recruiting.

Neonatal Opioid Withdrawal Syndrome is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program, running 2 of these trials.

Enrollment posture brief

Registry condition neonatal-opioid-withdrawal-syndrome

OPEN 2 | RECR 25% | LATE 3 | EARLY 0 | RANK #2176 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Neonatal Opioid Withdraw (th…25%
Open-enrollment share among volume-matched conditions near Neonatal Opioid Withdrawal Syndrome

Neonatal Opioid Withdrawal Syndrome lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Neonatal Opioid Withdrawal Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Neonatal Opioid Withdrawal Syndrome is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Neonatal Opioid Withdrawal Syndrome research.

    Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program accounts for 2 of 8 trials (25%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Neonatal Opioid Withdrawal Syndrome enrolment sits around 140 participants.

    Median target enrolment is 140 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.

  4. Neonatal Opioid Withdrawal Syndrome splits between interventional and observational designs.

    4 interventional and 4 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 32Phase 41

Phase Distribution

PhaseTrial count
Phase 3 2
Phase 4 1

Top Sponsors

Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program 2 trials
T. John Winhusen, PhD 2 trials
HELP for NOWS Consortium 1 trials
Milton S. Hershey Medical Center 1 trials
Spark Biomedical 1 trials
Indiana University 1 trials

Named interventions

Most-linked intervention names on Neonatal Opioid Withdrawal Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Buprenorphine Sublingual Product Drug
2 trials
Buprenorphine Injection Drug
2 trials
Morphine scheduled Drug
1 trials
Morphine PRN Drug
1 trials
Sham Sparrow Fledging Therapy System Device
1 trials
Sparrow Fledging Therapy System Device
1 trials
Buccal swab saliva for further genetic testing Genetic
1 trials
Morphine Drug
1 trials

US sites by state

Facility locations filed on Neonatal Opioid Withdrawal Syndrome trials. A trial with sites in several states counts in each.

Pennsylvania 5 trials
Ohio 5 trials
New Mexico 4 trials
South Carolina 3 trials
Massachusetts 3 trials
Florida 3 trials
Alabama 3 trials
West Virginia 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Neonatal Opioid Withdrawal Syndrome page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neonatal Opioid Withdrawal Syndrome condition card totals 8 registered trials; most-linked intervention Buprenorphine Sublingual Product; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.